Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM et al (2021) Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol 52(2):98–107
Jeffers LJ, Perez GO, de Medina MD, Ortiz-Interian CJ, Schiff ER, Reddy KR et al (1990) Hepatitis C infection in two urban hemodialysis units. Kidney Int 38(2):320–322
Article CAS PubMed Google Scholar
Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA et al (2004) Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 65(6):2335–2342
Goodkin DA, Bieber B, Gillespie B, Robinson BM, Jadoul M (2013) Hepatitis C infection is very rarely treated among hemodialysis patients. Am J Nephrol 38(5):405–412
Article CAS PubMed Google Scholar
Goodkin DA, Bieber B, Jadoul M, Martin P, Kanda E, Pisoni RL (2017) Mortality, hospitalization, and quality of life among patients with hepatitis c infection on hemodialysis. Clin J Am Soc Nephrol 12(2):287–297
Hu W, Zhang C, Shi JJ, Zhang JY, Wang FS (2020) Hepatitis C: milestones from discovery to clinical cure. Mil Med Res 7(1):59
PubMed PubMed Central Google Scholar
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61(1 Suppl):S45-57
Goel A, Seguy N, Aggarwal R (2019) Burden of hepatitis C virus infection in India: a systematic review and meta-analysis. J Gastroenterol Hepatol 34(2):321–329
Article CAS PubMed Google Scholar
da Costa-Marques-Borges LF, Zalis MG, Santoro-Lopes G, Varella RB (2019) Hepatitis C virus genotypes in hemodialysis patients in Angola. J Med Virol 91(3):518–521
Jakupi X, Mlakar J, Lunar MM, Seme K, Rudhani I, Raka L et al (2018) A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study. BMC Nephrol 19(1):304
Article CAS PubMed PubMed Central Google Scholar
Ozer Etik D, Ocal S, Boyacioglu AS (2015) Hepatitis C infection in hemodialysis patients: a review. World J Hepatol 7(6):885–895
Article PubMed PubMed Central Google Scholar
Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50(Rr-5):1–43.
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl 2018;8(3):91–165.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71
Article PubMed PubMed Central Google Scholar
The World Bank. World Bank Country and Lending Groups 2021 [Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519.
The World Bank. World Development Indicators database [Available from: https://data.worldbank.org/indicator/NY.GDP.MKTP.PP.KD?end=2020&start=1990&view=chart&fbclid=IwAR3plOdC1r1vKGhLJsz7s7819U3EEV267hK4tIHVCn-_YQj1QMs0FUUip3g.
Wells G, Shea B, O'Connell D, Peterson j, Welch V, Losos M et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000.
Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F et al (2015) The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 8(1):2–10
Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11(2):193–206
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Article CAS PubMed PubMed Central Google Scholar
Viechtbauer W. Conducting meta-analyses in R with the metafor Package. J Stat Softw. 2010;36.
Shimokura G, Chai F, Weber DJ, Samsa GP, Xia GL, Nainan OV et al (2011) Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol 32(5):415–424
Article PubMed PubMed Central Google Scholar
Pawlotsky JM (2002) Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73
Kamili S, Drobeniuc J, Araujo AC, Hayden TM (2012) Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 55(Suppl 1):S43–S48
Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J et al (2016) Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis. Ann Intern Med 165(5):345–355
Article PubMed PubMed Central Google Scholar
Hu KQ, Cui W (2016) A highly specific and sensitive hepatitis C virus antigen enzyme immunoassay for One-step diagnosis of viremic hepatitis C virus infection. Hepatology 64(2):415–424
Article CAS PubMed Google Scholar
Broumand B, Shamshirsaz AA, Kamgar M, Hashemi R, Aiazi F, Bekheirnia M et al (2002) Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in tehran: preliminary report from “the effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients” project. Saudi J Kidney Dis Transpl 13(4):467–472
Silva LK, Silva MB, Rodart IF, Lopes GB, Costa FQ, Melo ME et al (2006) Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res 39(5):595–602
Article CAS PubMed Google Scholar
Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M et al (1997) Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 92(1):73–78
Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ (2005) National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18(1):52–61
Jadoul M, Cornu C, van Ypersele-de-Strihou C (1998) Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int 53(4):1022–1025
Article CAS PubMed Google Scholar
Roth D, Bloom RD, Molnar MZ, Reese PP, Sawinski D, Sise ME et al (2020) KDOQI US Commentary on the 2018 KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C. Am J Kidney Dis 75(5):665–683
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264–73.e1
Faustini A, Colais P, Fabrizi E, Bargagli AM, Davoli M, Di Lallo D et al (2010) Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. BMC Infect Dis 10:97
Article PubMed PubMed Central Google Scholar
Nakayama E, Akiba T, Marumo F, Sato C (2000) Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11(10):1896–1902
Fabrizi F, Martin P, Dixit V, Messa P (2014) Meta-analysis of observational studies: hepatitis C and survival after renal transplant. J Viral Hepat 21(5):314–324
Article CAS PubMed Google Scholar
Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY et al (2012) Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis 206(4):469–477
Petta S, Maida M, Macaluso FS, Barbara M, Licata A, Craxì A et al (2016) Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies. Gastroenterology 150(1):145–55.e4 (quiz e15–6)
Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, Cyrus S et al (2008) Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol 167(6):743–750
Fabrizi F, Dixit V, Messa P (2019) Hepatitis C virus and mortality among patients on dialysis: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 43(3):244–254
Janjua NZ, Wong S, Abdia Y, Jeong D, Buller-Taylor T, Adu PA et al (2021) Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study. J Hepatol 75(5):1049–1057
Article CAS PubMed Google Scholar
EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020;73(5):1170–218.
Kirby BJ, Symonds WT, Kearney BP, Mathias AA (2015) Pharmacokinetic, pharmacodynamic, and drug-interaction profile of the hepatitis C virus NS5B polymerase inhibitor sofosbuvir. Clin Pharmacokinet 54(7):677–690
Article CAS PubMed Google Scholar
Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A et al (2016) Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C. J Hepatol 65(1):40–47
留言 (0)